Pramlintide as an Adjunct to Insulin Therapy Improves Long-Term Glycemic and Weight Control in Patients With Type 2 Diabetes

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

1998 • 19,638 citations

U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease

1995 • 1,880 citations

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1995 • 762 citations

Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study

1998 • 655 citations

Efficacy of Metformin in Type II Diabetes

1997 • 497 citations

Postprandial Blood Glucose

2001 • 441 citations

Epidemiology of severe hypoglycemia in the diabetes control and complications trial

1991 • 307 citations

A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes

2002 • 257 citations

Standards of Medical Care for Patients With Diabetes Mellitus

2002 • 250 citations

Intensive Conventional Insulin Therapy for Type II Diabetes: Metabolic effects during a 6-mo outpatient trial

1993 • 232 citations

Effects of Metformin in Patients with Poorly Controlled, Insulin-Treated Type 2 Diabetes Mellitus

1999 • 229 citations

Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin

1995 • 174 citations

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double‐blind, placebo‐controlled study

2000 • 174 citations

Dose-response for glucagonostatic effect of amylin in rats

1997 • 173 citations

Amylin Replacement With Pramlintide as an Adjunct to Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: A Physiological Approach Toward Improved Metabolic Control

2001 • 167 citations

Inhibition of Central Amylin Signaling Increases Food Intake and Body Adiposity in Rats

2001 • 164 citations

Adjunctive Therapy with the Amylin Analogue Pramlintide Leads to a Combined Improvement in Glycemic and Weight Control in Insulin-Treated Subjects with Type 2 Diabetes

2002 • 157 citations

Frequency and Symptoms of Hypoglycaemia Experienced by Patients with Type 2 Diabetes Treated with Insulin

1993 • 155 citations

The Human Amylin Analog, Pramlintide, Reduces Postprandial Hyperglucagonemia in Patients with Type 2 Diabetes Mellitus

2002 • 142 citations

Perceived symptoms of hypoglycaemia in elderly Type 2 diabetic patients treated with insulin

1998 • 136 citations

Amylin decreases food intake in mice

1991 • 133 citations

Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus

2002 • 107 citations

Pramlintide: A Human Amylin Analogue Reduced Postprandial Plasma Glucose, Insulin, and C-peptide Concentrations in Patients with Type 2 Diabetes

1997 • 73 citations

Unresolved Challenges with Insulin Therapy in Type 1 and Type 2 Diabetes: Potential Benefit of Replacing Amylin, a Second β-Cell Hormone

2002 • 72 citations

Amylin Replacement With Pramlintide in Type 1 and Type 2 Diabetes: A Physiological Approach to Overcome Barriers With Insulin Therapy

2002 • 71 citations

Postprandial hyperglycaemic state: importance and consequences.

1998 • 60 citations

The Medical Management of Hyperglycemia Over a 10-Year Period in People With Diabetes

1996 • 59 citations

The Cgrp Family: Calcitonin Gene-Related Peptide (Cgrp), Amylin and Adrenomedullin

1999 • 35 citations

Frequency of severe hypoglycaemia in type 1 and type 2 diabetes during conventional insulin therapy

2009 • 30 citations